Identification of tumour-associated and germ line p53 mutations in canine mammary cancer
1999
Canine Mammary Cancer and p53 Mutations
Sample size: 10
publication
Evidence: moderate
Author Information
Author(s): Veldhoen N, Watterson J, Brash M, Milner J
Primary Institution: YCR P53 Research Group, Department of Biology, University of York
Hypothesis
Do mutations in the p53 gene contribute to canine mammary cancer?
Conclusion
The study found p53 mutations in some dogs with mammary cancer, suggesting a link between these mutations and tumor formation.
Supporting Evidence
- p53 mutations were identified in three out of ten canine mammary cancer patients.
- The mutations included both tumor-associated changes and a germ line deletion.
- The findings suggest a role for p53 inactivation in the development of canine mammary tumors.
Takeaway
This study looked at dogs with breast cancer and found some had changes in a gene that helps prevent tumors, which might help us understand cancer in dogs and humans.
Methodology
The researchers isolated p53 cDNA from normal and tumor tissue of ten canine mammary cancer patients and performed DNA sequencing.
Participant Demographics
Ten canine patients with mammary cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website